GPP
Great Point Partners’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,691,768
| Closed | -$11.6M | – | 36 |
|
|
2023
Q3 | $11.6M | Sell |
1,691,768
-249,813
| -13% | -$1.71M | 2.11% | 18 |
|
|
2023
Q2 | $20.1M | Buy |
1,941,581
+750,000
| +63% | +$7.78M | 3.94% | 10 |
|
|
2023
Q1 | $9.64M | Buy |
1,191,581
+172,299
| +17% | +$1.39M | 1.89% | 22 |
|
|
2022
Q4 | $16.1M | Hold |
1,019,282
| – | – | 3.15% | 10 |
|
|
2022
Q3 | $16M | Sell |
1,019,282
-63,718
| -6% | -$1M | 3.86% | 10 |
|
|
2022
Q2 | $15.1M | Buy |
1,083,000
+140,555
| +15% | +$1.96M | 3.63% | 9 |
|
|
2022
Q1 | $16.2M | Buy |
942,445
+142,445
| +18% | +$2.46M | 3.93% | 14 |
|
|
2021
Q4 | $11.6M | Buy |
800,000
+300,000
| +60% | +$4.36M | 2.58% | 18 |
|
|
2021
Q3 | $9M | Buy |
+500,000
| New | +$9M | 2.1% | 22 |
|